WP
TNYA icon

Woodline Partners’s Tenaya Therapeutics TNYA Stock Holding History

Woodline Partners’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,916,167
Closed -$3.37M – 1045
2025
Q1 		$3.37M Buy
5,916,167
+5,896,873
+30,563% +$5.82M 0.02% 594
2024
Q4 		$27.6K Buy
+19,294
New +$43.3K ﹤0.01% 916
2024
Q3 		– Sell
-101,717
Closed -$315K – 704
2024
Q2 		$315K Buy
101,717
+45,717
+82% +$189K ﹤0.01% 518
2024
Q1 		$293K Buy
+56,000
New +$268K ﹤0.01% 502
2022
Q4 		– Sell
-200,698
Closed -$582K – 846
2022
Q3 		$582K Hold
200,698
– – 0.01% 586
2022
Q2 		$1.13M Buy
200,698
+163,130
+434% +$1.32M 0.02% 502
2022
Q1 		$443K Buy
+37,568
New +$455K 0.01% 520
2021
Q4 		– Sell
-150,080
Closed -$3.1M – 788
2021
Q3 		$3.1M Buy
+150,080
New +$3.22M 0.05% 333

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Woodline Partners's TNYA Position: Q2 2025 in Review

Woodline Partners sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 5,916,167 shares — an estimated $3.37M sold.

Woodline Partners first reported a position in TNYA in Q3 2021 and held it in 8 quarters. The position peaked at $3.37M in Q1 2025. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

  • Woodline Partners reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Woodline Partners sold 5,916,167 Tenaya Therapeutics shares in Q2 2025, an estimated $3.37M.
  • Woodline Partners first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 8 quarters.
  • Woodline Partners's Tenaya Therapeutics position peaked at $3.37M in Q1 2025.
  • 89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.